Product Images Escitalopram

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Escitalopram NDC 16571-755 by Rising Pharma Holdings, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Image - 77e6adf5 f122 42f1 a683 b8ace5df2a30 01

Image - 77e6adf5 f122 42f1 a683 b8ace5df2a30 01

image - 77e6adf5 f122 42f1 a683 b8ace5df2a30 02

image - 77e6adf5 f122 42f1 a683 b8ace5df2a30 02

This is a description of a medication called Escitalopram. It is available in tablet form, with each tablet containing 5 mg of escitalopram oxalate. The medication is to be dispensed along with a Medication Guide for each patient. The recommended storage temperature is between 20°C to 25°C, with excursions permitted between 15°C to 30°C. The medication should be dispensed in a tight container. The usual dosage should be determined based on the package insert. The medication was issued in May 2023. It is distributed by Rising Pharma Holdings, Inc. and manufactured by Graviti Pharmaceuticals Pvt. Ltd. in Telangana, India. The provided text also includes some unrelated information, such as license numbers and an unvarnished area measurement.*

image - 77e6adf5 f122 42f1 a683 b8ace5df2a30 03

image - 77e6adf5 f122 42f1 a683 b8ace5df2a30 03

image - 77e6adf5 f122 42f1 a683 b8ace5df2a30 04

image - 77e6adf5 f122 42f1 a683 b8ace5df2a30 04

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.